List of Papers Published in 2000

Clinical Laboratory Division

  1. Gabert HE, Shimoda T, Hainaut P. Squamous cell carcinoma of esophagus. In: Hamilton R, Aaltonen LA, editors. Pathology and Genetics, tumor of the digestive system. Lyon: WHO Classification of tumors. 2000:11-19.
  2. Hasegawa T, Seki K, Hasegawa F, Matsuno Y, Shimoda T, Hirose T, Sano T, Hirohashi S. Dedifferentiated liposarcoma of retroperitoneum and masentery:Varied growth patterns and histological grades- a clinicopathologic study of 32 cases. Hum Pathol 2000;31:717-727.
  3. Hayashi I, Tsuda H, Shimoda T. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix. Am J Surg Pathol 2000;24:559-562.
  4. Kanamoto A, Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y, Kato H, Watanabe H. A case of small polypoid esophageal carcinoma with multidirectional differentiation, including neuroendocrine, squamous, ciliated glandular, and sarcomatous components. Arch Pathol Lab Med 2000;124:1685-1687.
  5. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000;50:696-702.
  6. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factor-A,-B,-C,and -D and relationship to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000;6:2431-2139.
  7. Schlemper RJ, Dawsey SM, Itabashi M, Iwashita A, Kato Y, Lewin KJ, Riddell RJ, Shimoda T, Sipponen P, Stolte M, Watanabe H. Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and western pathologists. Cancer 2000;88:996-1006.
  8. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou J-F, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA. Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255.
  9. Tajima Y, Nakanishi Y, Ochiai A, Tachimori Y, Kato H, Watanabe H, Yamaguchi H, Yoshimura K, Kusano M, Shimoda T. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma. Cancer 2000;88:1285-1293.
  10. Tajima Y, Nakanishi Y, Tachimori Y, Kato H, Watanabe H, Yamaguchi H, Yoshimura K, Kusano M, Shimoda T. Significance of involvement by squamous cell carcinoma of the ducts of esophageal submucosal glands. Cancer 2000;89:248-254.
  11. Tomaru U, Hasegawa T, Hasegawa F, Kito M, Hirose T, Shimoda T. Primary extracranial meningioma of the foot: a case report. Jpn J Clin Oncol 2000;30:313-317.
  12. Fukushima N, Mukai K. Pancreatic cystic neoplasms with mucus production: differential diagnosis between intraductal papillary-mucinous tumors and mucinous cystic tumors. Int J Surg Pathol (in press)
  13. Fukushima N, Sakamoto M, Hirohashi S. Lamiminin-5 gamma2 chain expression in intraductal papillary mucinous tumors and invasive ductal adenocarcinomas. Modern Pathol (in press)
  14. Moriya Y, Niki T, Yamada T, Matsuno Y, Kondo H, Hirohashi S. Increased expression of laminin-5 and its prognostic significance in small sized lung adenocarcinoma: an immunohistochemicals of 102 cases. Cancrer (in press)
  15. Niki T, Iba S, Yamada T, Matsuno Y, Enholm B. Hirohashi, S. Expression of endothelial growth factor recepter 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol (in press)
  16. Tokunou M, Niki T, Eguchi K, Tsuda H, Yamada T, Matsuno Y, Kondo H, Saitoh Y, Imamura H. c-MET expression in myofibroblasts: role in autocrine activation and prognositic significance lung adenocarcinoma. Am J Pathol (in press)

Diagnostic Radiology Division

  1. Furukawa H, Fukushima N, Shimoda K. Splenic artery aneurysm secondary to pancreatic carcinoma. Am J Gastroenterol 2000;95:3659-3660.
  2. Furukawa H, Iwata R, Moriyama N, Kosuge T. Selective intraarterial contrast-enhanced CT of pancreaticoduoddenal tumors: early clinical experience in evaluating blood supply and detectability. Am J Roentgenol 2000;175:91-97
  3. Furukawa H, Sano K, Kosuge T, Shimoda K, Yamamoto J, Iwata R, Moriyama N. Hilar cholangiocarcinoma evaluated by three-dimensional CT cholangiography and rotating cine cholangiography. Hepatogastroenterology 2000;47:615-620.
  4. Furukawa H, Shimoda K, Iwata R, Moriyama N. Areplaced common hepatic artery running through the pancreatic parenchyma. Surgery 2000;127:711-712.
  5. Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, Sato M, Yamanaka N, Shimamura Y, Ohto M. Comparison of CT and resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. Am J Roentogenol 2000;175:699-704.
  6. Takayasu K, van Leeuwen DJ. Enbolization, chemoembolization and alternatives for liver cancer. van Leeuwen DJ. editors. Imaging in hepatobiliary and pancreatic disease: a practicalclinical approach.London: WB Saunders 2000;413-425.
  7. Takayasu K. Imaging after hepatobiliary and pancreatic surgery. van Leeuwen DJ. editors. Imaging in hepatobiliary and pancreatic disease: a practicalclinical approach.London: WB Saunders 2000;144-150.
  8. Furukawa H, Iwata R, Moriyama N. Is CT during arterial portography useful for the preoperative evaluation of liver? Pancreas (in press)
  9. Furukawa H, Iwata R, Moriyama N. Angiograpic assessment of the right hepatic artery for enbasement by hilar cholangiocartinoma:Comparison between antero-posterior and right anterior oblique projections. Cardiovasc Intervent Radiol (in press)
  10. Furukawa H, Iwata R, Moriyama N. Growth rate of pancreatic carcinoma: inirial clinical experience. Pancreas (in press)
  11. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, Moriyama N, Okusaka T, Okada S, Ueno H. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unfied helical CT and angiography system: analysis. Am J Roentogenol (in press)

Endoscopy Division

  1.        Kaneko M, Kusumoto M, Kobayashi T, Moriyama N, Naruke T, Ohmatsu H, Kakinuma R, Eguchi K, Nishiyama H, Matsui E. Computed tomography screening for lung carcinoma in 2000 Japan. Cancer 2000;89:2485-2488.
  2. Okabayashi T, Gotoda T, Kondo H, Inui T, Ono H, Saito D, Yoshida S, Sasako M, Shimoda T. Early carcinoma of the gastric cardia in Japan. Cancer 2000;89:2555-2559.
  3. Okabayashi T, Gotoda T, Kondo H, Ono H, Oda I, Fujishiro M, Yachida S. Usefulness of indigo carmine chromoendoscopy and endoscopic clipping for accurate preoperative assessment of proximal gastric cancer. Endoscopy 2000;32:562.
  4. Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, Chalmers DM, Axon ATR. Flat and depresed colonic neplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 2000;355:1211-1214.
  5. Saito Y, Kondo H, Yokota T, Fujii T, Ono H, Gotoda T, Takigawa T, Saito D, Ishikawa T, Akasu T, Shimoda T. A rectal carcinoid macroscopically simulating early cancer. Endoscoopy 2000;32:17-18.
  6. Toshiaki K, Masahiro K, Minako S, Kaoru K, Haruhiko K. CT-assisted transbronchial brachytherapy for small peripheral lung. Jpn J Clin Oncol 2000;30:109-112.
  7. Blaser MJ, Saito D. Trends in reported adenocarcinomas of the esophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol (in press)
  8. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y. Incidence of lymph node metastasis from early gastric cancer. Gastric Cancer (in press)

Breast and Endocrinology Division

  1. Katsumata N, Tsunematsu R, Tanaka K, Terashima Y, Ogita S, Hoshiai H, Kohno I, Hirabayashi K, Yakushiji M, Noda K, Taguchi T. A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: a Japanese Cooperative Study. Ann Oncol 2000;11:1531-1537.
  2. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. A quantative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinimas in a protocol study. Pathol Int 2000;50:119-125.
  3. Watanabe T. Sonoo H. Endocrine options for breast cancer treatment: looking beyond tamoxifen. Breast Cancer 2000;7:345-349.

Gastrointestinal Oncology Division

  1. Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T. Expression of CD44 variants and prognosis in thoracic esophageal squamous cell carcinoma. Gut 2000;46:14-19.
  2. Kanamitsu S, Ito K, Okuda H, Ogura K, Watabe T, Muro K, Sugiyama Y. Prediction of in vivo durg-drug interactions based on mechanism-based inhibition from in vitro data : inhibition of 5-fluorouracil metabolism by (E)-5-(2-bromovinyl) uracil. Drug Metab Dispos 2000;28:467-474.
  3. Kurata T, Shimada Y,Tamura T, Yamamoto N, Hyodo I, Saeki T, Takashima S, Fujiwara K, Wakasugi H, Kashimura M. Phase I and parmacokinetic study of a new taxoid, RPR109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors. J Clin Oncol 2000;18:3164-3171.
  4. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controlled Release 2000;35:271-284.
  5. Matsumura Y, Odaka S. Transcatheter therapy for liver metastasis from gastric cancer [Editional]. J Gastroennterol 2000;35:949-950.
  6. Yamada Y, Aiba K, Horikosi N, Hanai M, Uno S, Osawa H, Mizumura N, Takahashi S, Ito Y. Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer. J Clin Oncol 2000;5:18-21.
  7. Matsumura Y. DDS in cancer chemotherapy. In: Biomedical polymers and polymer therapeutics. London: Kluwer Academic / Plenum Publishers (in press)
  8. Mizumura Y, Matsumura Y, Hamaguchi T, Nishiyama N, Kataoka K, Kawaguchi T,William J.M.Hrushesky, Moriyasu F, Kakizoe T. Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res (in press)
  9.        Namiki Y, Muro K, Shirao K, Shimada Y, Matsumura Y, Yamada Y, Gotoh T, Hamaguchi T, Mizuno T, Ura T. Prognostic factors for patients with metastatic colorectal cancer receiving protracted venous infusion of 5FU. Am J Clin Oncol (in press)
  10. Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H, Miyata Y, Taguchi T. Phase II trial of pclitaxel by 3-Hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Annal Oncol (in press)

Hematology Division

  1. Ando M, Yokozawa T, Sawada J, Takaue Y, Togitani K, Kawahigashi N, Narabayashi M, Takeyama K, Tanosaki R, Mineishi S, Kobayashi Y, Watanabe T, Adachi I, Tobinai K. Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 2000;25:185-189.
  2. Gomyo H, Murayama T, Kizaki T, Mizuno I, Sao H, Tobinai K, Koizumi T, Imoto S. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;26:577-579.
  3. Itoh K, Ohtsu T, Sasaki Y, Ogura M,Morishima Y, Kasai M, Chou T, Yoshida K, Ohno T, MIzorogi F, Uike N, Sai T, Taniwaki M, Ikeda S, Tobinai K and Members of the Lenograstim/Lymphoma Study  Group. Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP in aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 2000;38:521-532.
  4. Murayama T, Takenaka T, Matsuno Y, Takeyama K, Togitani K, Yokozawa T, Kobayashi Y, Tobinai K. Successful allogeneic bone marrow transplantation in adult precursor B-lymphoblastic lymphoma. Int J Hematol 2000;72:504-506.
  5. Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K, Shimoyama M, and the Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG). Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: A multicenter phase II study (JCOG8905). Jpn J Clin Oncol 2000;30;146-152.
  6. Takeyama K, Seto M, Uike N, Hamajima N, Ino T, Mikuni C, Kobayashi T, Maruta A, Muto Y, Masaki N, Sakamaki H, Saitoh H, Shimoyama M, Ueda R. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. Int J Hematol 2000;71:144-152.
  7. Tobinai K. Adult T-cell leukemia-lymphoma. In: Abeloff MD editors. Clinical Oncology, second edition. New York: Churchill Livingstone Inc. 2000;2748-2768.
  8. Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T, Seto M, Nakamura S. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma (MCL): a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000;95:2253-2261.
  9. Yokozawa T, Towatari M, Iida H, Takeyama K, Tanimoto M, Kiyoi H, Motoji T, Asou N, Takeuchi M, Kobayashi Y, Miyawaki S, Kodera T, Ohno R, Saito H, Naoe T. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia. Leukemia 2000;14:28-33.
  10. Igarashi T, Ohtsu T, Fujii H, Morishima Y,Ogura M, Kagami Y, Kinoshita T, Kiyama Y, Tobinai K, and members of the IDEC-C2B8 Study Group. Re-treatment of relapsed indolent B-cell lymphoma with rituximab. Int J Hematol (in press)
  11. Kobayashi Y, Nakata M, Maekawa M, Takahashi M, Fujii H, Matsuno Y, Fujishiro M, Ono H, Saito D, Takenaka T, Tobinai K, Hirase N, Nihimura J, Akioka T, Enomoto K, Mikuni C, Hayashi Y, Fukayama M, Ohki M. Detection of t(11;18) MALT lymphoma with dual color fluorescence in situ hybridization and/or RT-PCR. Diag Mol Pathol (in press)

Hematopoietic Stem Cell Transplantation Team

  1. Azuma M, Kato K, Ikarashi Y, Asada-Mikami R, Maruoka H, Takaue Y, Saito A, Wakasugi H. Cytokines productionof U5A2-13-positive T cells by stimulation with glycolipid a-galactosylceramide. Eur J Immunol 2000;30:2138-2146.
  2. Horikoshi Y, Mimaya J, Kawano Y, Watanabe A, Watanabe T, Sekine I, Nishikawa K, Tsunematsu Y, Endo M, Eguchi H, Koyama T, Kawakami K, Oka T, Matsushita T, Koizumi S, Ohira M, Fujimoto T, Takaue Y. Feasibility studyof autologous peripheral blood stemcell transplantation for the treatment of childhood acute myelogenous leukemia. Jpn J Clin Oncol 2000;30:137-145.
  3. Kanamaru S, Kawano Y, Watanabe T, Nakagawa R, Suzuya H, Onishi T, Yamasaki J, Nakayama T, Kuroda Y, Takaue Y. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result In delayed platelet recovery after cordblood cell transplant. Stem Cells 2000;18:190-195.
  4. Kawano Y, Miyazaki T, Watanabe T, Suzue A, Kan-nuki S, Kagechi T, Onishi T, Kaneko M,Kanamaru S, Wakata Y, Nakagawa R, Suenaga K, Suzuya H, Abe T, Nagahiro S, Kuroda Y, Takaue Y. HLA-mismatched CD34-selected stem cell transplant complicated by HHV-6 reactivation in the central nervous system. Bone Marrow Transplant 2000;25:787-790.
  5. Kawano Y, Watanabe T, Okamoto Y, Abe T, Kuroda Y, Takaue Y, Watanabe A. Autologous and allogeneic transplantation with blood CD34+ cells: a pediatric experience. In: Ho AD, Haas R, Champlin R, Haas R, Champlin R, editors. Hematopoietic Stem Cell Transplantation. New York: Marcel Dekker, Inc 2000;239-249.
  6. Saito T, Seo S, Tanosaki R, Takaue Y, Mineishi S. Non-myeloablative stem cell transplantation using 2-chlorodeoxyadenosine (2-CdA) in a patient with myelodysplastic syndrome. Exp Oncol 2000;22:88-90.
  7. Watanabe T, Kajiume T, Abe T, Kawano Y, Iwai A, Iwai T, Takaue Y, Kuroda Y. Allogeneic peripheral blood stem cell transplantation in children with hematological malignancies from HLA-matched siblings. Med Pediatr Oncol 2000;34:171-176.
  8. Asada-Mikami R, Heike Y, Takaue T, Krasnykh V, Curiel DT, Wakasugi H. Efficient gene transfection by RGD-fibermodified recombinant adenoviruse to dendritic cells. Jpn J Cancer Res (in press)
  9. Kanda Y, Mineishi S, Saito T, Seo S, Saito A, Ohnishi M, Suenaga K, Niiya H, Nakai K, Takeuchi T, Kawahigashi Y, Shoji N, Ogasawara T, Tanosaki R, Kobayashi Y, Tobinai K, Kami M, Mori S, Suzuki R, Kunitoh H, Takaue Y. Pre-emptive therapy against cytomegalovirus (CMV) diseases guided by CMV antigenemia assay after allogeneichematopoietic stem cell transplantation. A single-center experience in Japan. Bone Marrow Transplant (in press)
  10. Matsubara H, Makimoto A, Takayama J, Higa T, Saito T, Tanosaki R, Mineishi S, Ohira M, Takaue Y. Suggested clinicalbenefits of the use of peripheral blood stem cells over bone marrow in allogeneic transplantatio settings for the treatment of childhood leukemia. Jpn J Clin Oncol (in press)
  11. Mineishi S, Saito T, Kanda Y, Tanosaki R, Tobinai K, Takaue Y. Delayed recovery of neutrophil counts after peripheralstem cell transplantation which improved with minimal dose of G-CSF administration. Jpn J Clin Oncol (in press)
  12. Saito T, Seo S, Kanda Y, Shoji N, Ogasawara T, Murakami J, Tanosaki R, Tobinai K, Takaue Y, Mineishi S. Early onset pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation. Am J Hematol (in press)
  13. Suenaga K, Kanda Y, Niiya H, Nakai K, Saito T, Saito A, Ohnishi M, Takeuchi T, Tanosaki R, Makimoto A, Makimoto A, Miyawaki S, Ohnishi T, Kanai S, Takaue Y, Mineishi S. Successful application of non-myeloablative transplantation for paroxysmal nocturnal hemoglobinuria. Exp Hematol (in press)
  14. Watanabe T, Mineishi S, Kawano Y, Takaue Y. Partially matched transplants with allogeneic CD34+ blood cells. Leuk Lymphoma (in press)

Hepatobiliary and Pancreatic Oncology Division

  1. Fujishiro M, Okada S, Ueno H, Okusaka T, Ikeda M, Watanabe H, Tanaka N. Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer. Hepatogastroenterology 2000;47:1744-1746.
  2. Ikeda M, Okada S, Ueno H, Okusaka H, Tanaka N, Kuriyama H, Yoshimori M. A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer. Hepatogastroenterology 2000;47:862-865.
  3. Matsuno S, Okada S, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Katoh H, Suda K, Nakao A, Isaji S, Hiraoka T, Hosotani R, Imaizumi T. Pancreaic cancer: current status of treatment and survival of 16071 patients diagnosed from 1981-1996, using the Japanese National pancreatic Cancer Database. Int J Clin Oncol 2000;5:153-157.
  4. Okada S, Abo T. Spontaneous regression of hepatocellular carcinoma. J Gastroen Hepatol 2000;15:965-966.
  5. Okada S. How to manage hepatic vein tumor thrombus in hepatocellular carcinoma. J Gastroen Hepatol 2000;15:346-348.
  6. Okada S. How can we avert hepatic vascular complications in SMANCS therapy for hepatocellular carcinoma ? J Gastroenterol 2000;35:407-409.
  7. Okusaka T, Okada S, Ueno H, Ikeda M, Yoshimori M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Iwata R, Furukawa H, Moriyama N, Sakamoto M, Hirohashi S. Evaluation of therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology 2000;58:293-299.
  8. Tanaka N, Okada S, Ueno H, Okusaka T, Ikeda M. The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer. Pancreas 2000;20:378-381.
  9.         Tokuuye K, Sumi M, Kagami Y, Murayama S, Kawashima M, Ikeda M, Ueno H, Okusaka T, Okada S. Radiotherapy for hepatocellular carcinoma. Strahlenther Onkol 2000;176:406-410.
  10. Ueno H, Okada S, Okusaka T, Ikeda M. Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 2000;59:296-301.
  11. Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka H. Prognostic factors in patients with locally advanced pancreatic cancer receiving chemoradiotherapy. Cancer (in press)
  12.        Mashige F, Okada S, Tsuno HH, Maekawa M, Tanaka N, Matsui S, Watanabe S, Nakahara K. Noninvasive combination assay of free L-fucose and sulfated bile acids in urine for diagnosis of liver and pancreatic diseases and solid tumor. Ann Clin Biochem (in press)
  13. Okada S, Okuda K. Management of hepatocellular carcinoma: current practice and future options. Int J Gastroenterol (in press)
  14. Okada S, Sato T, Yamamoto S. Adjuvant interferon for hepatocellular carcinoma. Hepatology (in press)
  15. Okada S, Ueno H, Okusaka T, Ikeda M, Furuse J, Maru Y. Phase I trial of gemcitabine in patients with advanced pancreatic cancer. Jpn J Clin Oncol (in press)
  16. Okusaka T, Okada S, Tokuuye K, Wakasugi H, Saisho H, Ishikawa O, Matsuno S, Sato T, Sato K for the Non-surgical Treatment Group for Pancreatic Cancer in Japan. Lack of effectiveness of chemoradiotherapy combined with cisplatin for locally advanced pancreatic cancer. Cancer (in press)
  17. Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N, Sakamoto M. Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathological findings. Pancreas (in press)
  18. Ueno H, Okada S, Okusaka T, Ikeda M, Tanaka N, Sakamoto M, Yoshimori M. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Hepatogastroenterology (in press)

Pain Medicine and Palliative Care Division

  1. Shimoyama M, Shimoyama N, Hori Y. Gabapentin affects glutamatergic excitatory enurotransmission in the rat dorsal horn. Pain 2000;85:405-414.
  2. Shimoyama M, Shimoyama N. Antinociceptive and respiratory effects of intrathecal DALDA and DALDA analog. J Pharmacol Exp Ther (in press)

Pediatric Oncology Division

  1. Kigasawa H, Kato S, Akiyama Y, Imaizumi M, Ohira M, Kawa K, Hanada R, Matsuyama T, Ikuta K, Nishihira H, Yabe H, Tsuchida M, Okamura J, Mugishima H, Hoshi Y, Nagao T. National registry of hematopoietic stem-cell transplantation in children-1998-. Japanese Journal of Pediatric Hematology 2000;14:317-327.
  2. Matsubara H, Makimoto A, Takayama J, Higa T, Saito T, Kanda Y, Tanosaki R, Mineishi S, Ohira M, Takaue Y. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia. Jpn J Clin Oncol (in press)
  3. Ohnuma K, Isoyama K, Ikuta K, Toyoda Y, Nakamura J, Nakajima F, Tsuchida M, Ohira M, Suminoe A, Hara T, Nishihira H. Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with hematologic malignancies. Br J Hematol (in press)

Psycho-Oncology Division

  1. Akechi T, Fukue-Saeki M, Kugaya A, Okamura H, Nishiwaki Y, Yamawaki S, Uchitomi Y. Psychometric properties of the Japanese version of the Mental Adjustment to Cancer (MAC) Scale. Psycho-Oncology 2000;9:395-401.
  2. Akechi T, Okamura H, Kugaya A, Nakano T, Nakanishi T, Akizuki N, Yamawaki S, Uchitomi Y. Suicidal ideation in cancer patients with major depression. Jpn J Clin Oncol 2000;30:221-224.
  3. Akechi T, Okuyama T, Nakano T, Kitano S, Akizuki N, Okamura H, Uchitomi Y. Suicidal ideation in unresectable lung cancer patients. Proceedings of the 47th Annual Meeting of Academy of Psychosomatic Medicine 2000;1.
  4. Kugaya A, Akechi T, Okuyama T, Nakano T, Mikami I, Okamura H, Uchitomi Y. Prevalence, predictive factors, and screening of psychological distress in patients with newly diagnosed head and neck cancer. Cancer 2000;88:2817-2823.
  5. Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, Akechi T, Uchitomi Y. Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat 2000;6:131-137.
  6. Okamura H, Yamamoto N, Watanabe T, Katsumata N, Takashima S, Adachi I, Kugaya A, Akechi T, Uchitomi Y. Understanding of their own disease and survival potential in patients with metastatic breast cancer. Breast Cancer Res Treat 2000;61:145-150.
  7. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Mikami I, Hosaka T, Uchitomi Y. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 2000;8:215-222.
  8. Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M, Hosaka T, Uchitomi Y. Development and validation of the Cancer Fatigue Scale: a brief, three dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 2000;19:5-14.
  9. Oyama H, Kaneda M, Katsumata N, Akechi T, Ohsuga M. Using the bedside wellness system during chemotherapy decreases fatigue and emesis in cancer patients. J Med Syst 2000;24:173-182.
  10. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Development and validation of the cancer dyspnoea scale: a multidimensional, brief, self-rating scale. Br J Cancer 2000;82:800-805.
  11. Uchitomi Y, Mikami I, Kugaya A, Akizuki N, Nagai K, Nishiwaki Y, Akechi T, Okamura H. Depression after successful treatment for non-small cell lung cancer: a 3-month follow-up study. Cancer 2000;89:1172-1179.
  12. Akechi T, Nakano T, Okamura H, Ueda S, Akizuki N, Nakanishi T, Yoshikawa E, Matsuki H, Hirabayashi E, Uchitomi Y. Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol (in press)
  13. Akechi T, Okamura H, Yamawaki S, Uchitomi Y. Why do some cancer patients with depression desire an early death and others do not? Psychosomatics (in press)
  14. Akechi T, Okuyama T, Imoto S, Yamawaki S, Uchitomi Y. Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients. Breast Cancer Res Treat (in press)
  15. Okuyama T, Keiko Tanaka, Akechi T, Okamura H, Nishiwaki Y, Hosaka T, Uchitomi Y. Fatigue in ambularoty patients with lung cancer -prevalence, correlated factors, and screening-. J Pain Symptom Manage (in press)
  16. Uchitomi Y, Kugaya A, Akechi T, Nakano T, Wenner M, Okamura H, Takebayashi M, Kagaya A, Saeki T, Yamawaki S. Three sets of diagnostic criteria for major depression and correlations with serotonin-induced platelet calcium mobilization in cancer patients. Psychopharmacology (in press)

Thoracic Oncology Division

  1. Fujishiro M, Shinkai T, Fukuda M, Tamura T, Ohe Y, Kunitoh H, Nishiwaki Y, Sekine I, Fukuda H, Saijo N. Phase I study of weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408. Jpn J Clin Oncol 2000;30:487-493.
  2. Fukuoka K, Yamagishi T, Ichihara T, Nakaike S, Iguchi K, Yamada Y, Fukumoto H, Yoneda T, Samata K, Ikeya H, Nanaumi K, Hirayama N, Narita N, Saijo N, Nishio K. Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G1 phase of the cell cycle. Int J Cancer 2000;88:810-819.
  3. Harada T, Takaba K, Hara T, Yamamoto N, Tamura T, Saijo N, Ishii A. Inhibitory Effects of repeated intravenous injections of dexamethasone on pulmonary toxicity of a new mitomycin C analogue, KW-2149, in a novel rat model. J Toxicol Sci 2000;25:11-15
  4. noue A, Kunito H, Sekine I, Tokuue K, Sumi M, Saijo N. Radiation pneumonitis in lung cancer patients: retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys (in press)
  5. Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, Kurita Y, Saijo N. Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small cell lung cancer: Long term follow up results JCOG 8902. Ann Oncol 2000;11:445-450.
  6. Kurata T, Tamura T, Sasaki Y, Fujii H, Negoro S, Fukuoka M, Saijo N. Pharmacokinetic and pharamacodynamic analysis of JM-216. Jpn J Clin Oncol 2000;30:377-384.
  7. Moriyama E, Yokose T, Kodama T, Matsuno Y, Hojo F, Takahashi K, Nagai K, Nishiwaki Y, Ochiai A. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in the thymus of a patient with pulmonary amyloid nodules. Jpn J Clin Oncol 2000;30:349-353.
  8. Nakamura Y, Kunitoh H, Kubota K, Sekine I, Shinkai T, Tamura T, Kodama T, Sumi M, Kohno S, Saijo N. Platinum-based chemotherapy with or without TRT in patients with unresectable thymic carcinoma. Jpn J Clin Oncol 2000;30:385-388.
  9. Nakamura Y, Sekine I, Furuse K, Saijo N. Retrospective comperison of toxicity and efficacy in phase II trials of 3h infusions of paclitaxel for patients 70 years of age or older and patients under 70 years old. Cancer Chemother Pharmacol 2000;46:114-118.
  10. Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lang Cancer 2000;27:159-167.
  11. Saijo N, Tamura T, Nishio K. Problems in the development of target-based drugs. Cancer Chemother Pharmacol 2000;46: S43-45.
  12.    Saijo N. CPT-11/cisplatin in small cell lung cancer. Adv. In Lung Cancer 2000;4: 2-4.
  13. Sato Y, Tsuchiya B, Urao T, Baba H, Shiku H, Kodama T, Kameya T. Semiquantitative immunoblot analysis of nm23-H1 and nm23-H2 isoforms inadenocarcinomas of the lung: Prognostic significance. Pathol Int 2000;50:200-205.
  14. Sekine I, Matsuda T, Saisho T, Watanabe H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Saijo N. Bacterial meningits observed in a phase I trial of vinorelbine, cisplatin and thoracic radiotherapy for NSCLC: report of a case and discussion on dose limiting toxicity. Jpn J Clin Oncol 2000;30:401-405.
  15. Sekine I, Saijo N. Nobel combination chemotherapy in the treatment of non-small cell lung cancer. Exp Opin Pharmacol 2000;1:1131-1161
  16. Tamura T. New state of the art in small-cell lung cancer. Oncology 2000;15:8-10.
  17. Yamamoto N, Tamura T, Kamiya Y, Sekine I, Kunitoh H, Saijo N. Correlation between docetaxel clearance and estimated cytochrome p450 activity by urinary metabolite of exogenous cortisol. J Clin Oncol 2000;18:2301-2308.
  18. Kawahara M, Kris M, Green M, Kunitoh H. New drug and multimodality combinations in the treatment of advanced non-small cell lung cancer. Semin Oncol (in press)
  19. Kunitoh H, Nakamura Y, Aono H, Kamiya Y, Itoh R, Onodera R, Nakamura N, Sekine I, Kubota K, Tamura T, Shinkai T, Kodama T, Goto K, Hosomi Y, Niho S, Ohe Y, Nishiwaki Y, Saijo N. A phase I/II trial of cisplatin, ifosfamide in advanced or recurrent non-small lung cancer. Lung Cancer (in press)
  20. Ohe Y, Niho S, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Kunitoh H, Saijo N, Nishiwaki Y. Phase I studies of cisplatin and docetaxel administered by 3 consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients. Jpn J Clin Oncol (in press)
  21. Ohe Y, Saijo N. Topoisomerase I targeting agents in small-cell lung cancer. Curr Oncol Rep (in press)
  22. Ohe Y, Yamamoto S, Suzuki K, Hojo F, Kakinuma R, Matsumoto T, Ohmatsu H, Nishiwaki Y. Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer (in press)
  23. Saijo N, Nishio K, Tamura T. Preclinical and clinical trials of topoisomerase inhibitiors in Japan. Proc NY Acad Sci (in press)
  24. Saijo N, Nishio K, Tamura T. New strategies of cancer therapy in 21 century. Cancer Chemother Pharmacol (in press)
  25. Sekine I, Saijo N. Biology of lung cancer. Clin Lung Cancer (in press)
  26. Takama H, Tanaka H, Sudo T, Tamura T, Tanigawara Y. Population pharmacokinetic modeling and model validation of spicamycin derivative, KRN5500, in phase I study. Cancer Chemother Pharmacol (in press)

Radiation Oncology Division

  1. Ikushima H, Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, Tanaka M, Oyama H, Shibui S, Nomura K. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiol Oncol Biol Phys 2000;48:1389-1393.
  2. Imoto S, Fukukita H, Murakami K, Ikeda H, Moriyama N. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol 2000;73:130-133.
  3. Nakayama H, Tokuuye K, Kagami Y, Sumi M, Murayama S, Kawashima M, Imai A, Ikeda H, Tobinai K. Brain involvement in Hodgkin's disease: case reports and review of the literature. Radiat Med 2000;18:205-208.
  4. Oguchi M, Ikeda H, Isobe K, Hirota S, Hasegawa M, Nakamura K, Sasai K, Hayabuchi N. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 2000;48:161-168.
  5. Sumi M, Ikeda H, Tokuuye K, Tobisu K, Kakizoe T, Kagami Y, Murayama S. The external radiotherapy with 3-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma. Int J Radiat Oncol Biol Phys 2000;48:519-528.
  6. Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, Kaneko A, Akine Y. Long-term observations of a patient with choroidal melanoma following fractionated stereotactic radiotherapy: a case report. Acta Ophthalmol Scand 2000;78:477-479.
  7. Tokuuye K, Tokita N, Akine Y, Nakayama H, Sakurai H, Kobayashi T, Kanda K. Comparison of radiation effects of gadolinium and boron neutron capture reactions. Strahlenther Onkol 2000;176: 81-83
  8. Ikeda H. Structure of radiotherapy in Japan [Editorial]. Jpn J Clin Oncol (in press)

Breast Surgery Division

  1. Akashi-Tanaka S, Fukutomi T, Miyakawa K, Nanasawa T, Matsuo K, Hasegawa T, Tsuda H. Treatment of noninvasive carcinoma: Fifteen-year results at National Cancer Center Hospital in Tokyo. Breast Cancer 2000;7:341-344.
  2. Ashida A, Fukutomi T, Tsuda H, Akashi-Tanaka S, Ushijima T. Atypical medullary carcinoma of the breast with cartilaginous metaplasia in a patient with a BRCA1 germline mutation. Jpn J Clin Oncol 2000;30:30-32.
  3.    Higashi H, Fukutomi T, Watanabe T, Adachi I, Narabayashi M, Shibui S, Hokamura N, Akashi-Tanaka S. Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases. Breast Cancer 2000;7:153-156.
  4. Nakamura T, Fukutomi T, Tsuda H, Akashi-Tanaka S, Matsuo K, Shimizu C, Miyakawa K. Changes in findings of mammography, ultrasonography and contrast-enhanced computed tomography of three histological complete responders with primary breast cancer before and after neoadjuvant chemotherapy: case reports. Jpn J Clin Oncol 2000;30:453-457.
  5. Shimizu C, Fukutomi T, Tsuda H, Akashi-Tanaka S, Watanabe T, Nanasawa T, Sugihara K. c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues. J Surg Oncol 2000;73:17-20.
  6. Sugano K, Ushiama M, Fukutomi T, Tsuda H, Kitoh T, Ohkura H. Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse. Int J Cancer 2000;89:329-336.
  7. Tsuda H, Takarabe T, Akashi-Tanaka S, Fukutomi T, Nanasawa T, Watanabe T. Evaluation of histological criteria for identifying node-negative breast cancer with high risk of early recurrence in the NSAS-BC protocol study. Breast Cancer 2000;7:201-209.
  8. Tsuda H, Takarabe T, Fukutomi T, Hirohashi S. Preferential occurrence of carcinomas with loss of chromosome 16q and der(16)t(1;16)/der(1;16) in middle-aged patients with hyperplasia of mammary glands. Jpn J Cancer Res 2000;91:692-699.
  9. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi S. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 2000;24:197-202.
  10. Tsuda H, Tani Y, Hasegawa T, Fukutomi T. Concordance in judgments among c-erbB-2 (HER2/neu) overexpression detected by two immunohistochemical tests and gene amplification detected by southern blot hybridization in breast carcinoma. Pathol Int 2001;51:26-32.
  11. Akashi-Tanaka S, Fukutomi T, Miyakawa K, Nanasawa T, Matsuo K, Hasegawa T, Tsuda H. Constrast-enhanced computed tomography diagnosing the intraductal component and small invasive foci of breast cancer. Breast Cancer (in press)
  12. Akashi-Tanaka S, Fukutomi T, Watanabe T, Katsumata N, Nanasawa T, Matsuo K, Miyakawa K, Tsuda H. Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy. Int J Cancer (Radiat Oncol Invest) (in press)
  13. Fukutomi T, Akashi-Tanaka S, Nanasawa T, Matsuo K, Shimizu C. Multicentricity and histopathological features of familial breast cancers stratified by menopausal status. Int J Clin Oncol (in press)
  14. Matsuo K, Fukutomi T, Tsuda H, Hasegawa T, Akashi-Tanaka S, Nanasawa T. A case of malignant phyllodes with osteosarcomatous feature of the breast. Breast Cancer (in press)
  15. Tsuda H, Takarabe T, Akashi-Tanaka S, Fukutomi T, Hirohashi S. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and ductal carcinoma which occurred metachronously in the same area of the breast. Mod Pathol (in press)

Colorectal Surgery Division

  1. 162.    Akasu T, Asamura H. Robotic surgery. Jpn J Clin Oncol 2000;30:371-372.
  2. Akasu T, Kondo H, Moriya Y, Sugihara K, Gotoda T, Fujita S, Muto T, Kakizoe T. Endorectal ultrasonography and treatment of early stage rectal cancer. World J Surg 2000;24:1061-1068.
  3. Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, Saito T. Dermatomyositis accompanied by rectal cacner: report of a case. Surg Today 2000;30:302-304.
  4. Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 2000;30:7-11.
  5. Hasebe T, Matuno M, Sasaki S, Shimoda T, Sugitou M, Moriya Y, Ono M, Arai T, Ochiai A. Tumor thickness is a histopathologic predictive parameter of tumor metastasis and prognosis in patients with Dukes stage C ulcerative-type colorectal carcinoma. Cancer 2000;89:35-45.
  6.    Iwasaki Y, Moriya Y, Miyake H, Akasu T, Fujita S. En bloc surgery for colon cancer: report of a case. Surg Today 2000;30:191-194.
  7.    Maas CP, Moriya Y, Steup WH, van de Velde JCH. A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands. Eur J Surg Oncol 2000;26:751-757.
  8. Nomura S, Sugano K, Kashiwabara H, Taniguchi T, Fukayama N, Fujita S, Akasu T, Moriya Y, Ohhigashi S, Kakizoe T, Sekiya T. Enhanced detection of deleterious and other germline mutations of hMSH2 and hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Biochem Biophys Res Commun 2000;271:120-129.
  9. Ymaguchi T, Moriya Y, Fujii T, Kondo H, Oono Y, Shimoda T. Anal canal squamous-cell carcinoma in situ, clearly demonstrated by indigo carmine dye spraying. Dis Colon Rectum 2000 44:1161-1163.

Dermatology Division

  1. Takata M, Hashimoto K, Mehregan P, Lee MW, Yamamoto A, Mohri S, Ohara K, Takehara K. Genetic changes in sweat gland carcinomas. J Cutan Pathol 2000;27:30-35.
  2. Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg (in press)

Esophageal Surgery Division

  1.     Hokamura N, Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Nakanishi Y. Preoperative chemotherapy for esophageal carcinoma with intramural metastasis. J Surg Oncol 2000;75:117-121.
  2. Igaki H, Kato H, Tachimori Y, Nakanishi Y. Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus. J Surg Oncol 2000;75:37-41.
  3. Kato H, Igaki H, Tachimori Y, Watanabe H, Tsubosa Y, Nakanishi Y. Assessment of cervical lymph node metastasis in the staging of thoracic esophageal carcinoma. J Surg Oncol 2000;74:282-285.
  4. Watanabe H, Kato H, Tachimori Y. Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res 2000;155:123-133.

Gastric Surgery Division

  1. Fenoglio-Preiser C, Carneiro F, Correa P, Guilford P, Lambert R, Megraud F, Munoz N, Powell SM, Rugge M, Sasako M, Stolte M, Watanabe H. Tumours of the stomach. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours - Tumours of the Digestive System. Lyon: IARC Press 2000
  2. Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma. Cancer 2000;88:1796-1800.
  3. Nomura S, Sasako M, Katai H, Sano T, Maruyama K. Decreasing complication rates with stapled esophagojejunostomy following a learning curve. Gastric Cancer 2000;3:97-101.
  4. Sano T, Katai H, Sasako M, Maruyama K. Gastric lymphography and detection of sentinel nodes. Recent Results Cancer Res 2000;157: 253-258.
  5.    Sano T, Katai H, Sasako M, Maruyama K. The management of early gastric cancer. Surg Oncol 2000;9:17-22.
  6. Sano T. Treatment of primary gastric lymphoma: experience in the National Cancer Center Hospital Tokyo. Recent Results Cancer Res 2000;156:104-107.
  7. Sasako M, Katai H, Sano T, Maruyama K. Management of complications after gastrectomy with extended lymphadenectomy. Surg Oncol 2000;9:31-34.
  8. Sasako M. What is reasonable treatment for gastric adenocarcinoma? J Gastroenterol 2000;35 Suppl XII:116-120.
  9. Sasako M. Surgery for gastric cancer. In: Johnson CD, Taylor I, editors. Recent Advances in Surgery 23. London: Churchill Livingstone 2000;11-21.
  10. Watanabe H, Mai M, Shimoda T, Tatematsu M, Ochiai A, Mori M, Sano T, Aiko T, Yoshida S, Furukawa H, Kaminishi M, Koike M. Meeting report of the 72nd Japanese Gastric Cancer Congress. Gastric Cancer 2000;3:1-8.
  11. Davis P, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol (in press)
  12. Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg (in press)
  13. Sano T, SasakoM. Green tea and gastric cancer. N Engl J Med (in press)
  14. Yamaguchi T, Sano T, Katai H, Sasako M, Maruyama K. Node-positive mucosal gastric cancer: a follow-up study. Jpn J Clin Oncol (in press)

Gynecology Division

  1. Kasamatsu T, Shiromizu K, Kuwashima Y, Uehara T, Sakamoto H, Takahashi M. Fine needle aspiration cytology of adenocarcinoma of the rectovaginal septum. Acta Cytol 2000;44:831-834.
  2. Tsuda H, Okada S, Kasamatsu T. Is florid pyloric metaplasia different from adenoma malignum? Gynecol Oncol 2000;77:341-342.

Hepatobiliary and Pancreatic Surgery Divison

  1. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Konishi M, Kinoshita T, Miyagawa S, Kawasaki S. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498-505.
  2. Matsuo K, Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Sakamoto M, Takayama T, Makuuchi M. Resection of liver granulomas under a diagnosis of metastases from breast cancer. Abdom Imaging 2000;25:259-262.
  3. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, Yamamoto J, Imamura H. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-499.
  4. Ohkubo T, Yamamoto J, Sugawara Y, Shimada K, Yamasaki S, Makuuchi M, Kosuge T. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 2000;191:657-660.
  5. Okano K, Yamamoto J, Kosuge T, Yamamoto S, Sakamoto M, Nakanishi Y, Hirohashi S. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer 2000;15;89:267-275.
  6. Ozaki H, Kinoshita T, Kosuge T, Shimada K, Yamamoto J, Tokuuye K, Fukushima N, Mukai K. Long-term survival after multimodality treatment for resectable pancreatic cancer. Int J Pancreatol 2000;27:217-224.
  7. Sato H, Sugawara Y, Yamasaki S, Shimada K, Takayama T, Makuuchi M, Kosuge T. Thoracoabdominal approaches versus inverted T incision for posterior segmentectomy in hepatocellular carcinoma. Hepatogastroenterology 2000;47:504-506.
  8. Shimada K, Yamamoto J, Kosuge T, Sugawara Y, Yamasaki S. Complete drainage of pancreatic juice from the cut edge of the pancreas after subtotal left-side pancreatectomy. Hepatogastroenterology 2000;47:1156-1158.
  9. Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T, Makuuchi M. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 2000;190:446-450.
  10. Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Sakamoto M. Cystic liver metastases from colorectal cancer. J Surg Oncol 2000;74:148-152.
  11. Sugihara K, Yamamoto J. Surgical treatment of colorectal liver metastases. Ann Chir Gynaecol 2000;89:221-224.
  12. Sugawara Y, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Makuuchi M. Preoperative portal vein embolization for the patients with hepatocellular carcinoma. Surgery (in press)
  13. Takigawa Y, Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Makuuchi M. New lesion detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma. Ultrasound Med Biol (in press)

Neurosurgery Division

  1. Nomura K. Present status of brain tumor statistics in Japan. Int J Clin Oncol 2000;5:355-360.
  2. Tanaka M, Shibui S, Nomura K, Nakanishi Y, Hasegawa T, Hirose T. Malignant intracerebral nerve sheath tunor with intratumoral calcification. Case report. J Neurosurg 2000;92:338-341.

Ophthalmology Division

  1. Horie K, Insel PA. Retrovirally mediated transfer of a G protein-coupled receptor kinase (GRK) dominant-negative mutant enhances endogenous calcitonin receptor signaling in chinese hamster ovary cells. J Biol Chem 2000;275:29433-29440.
  2. Kawamura A Jr, Sekine T, Sekiguchi M, Yanoma S, Kaneko A, Haneda T, Moriya Y, Hayasaka K, Kakizoe T. Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy. Jpn J Clin Oncol 2000;30:267-271.
  3. Inoue S, Ogawa S, Horie K, Hoshino S, Goto W, Hosoi T, Tsutsumi O, Muramatsu M, Ouchi Y. An estrogen receptor b (ERb) isoform that lacks exon 5 has dominant negative activity on both ERa and ERb. Biochem Biophys Res Commun (in press)

Orthopedic Division

  1. Hasegawa T, Yokoyama R, Lee YH, Shimoda t, Beppu Y, Hirohashi S. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma. Oncology 2000;58:66-74.
  2. Kimura K, Shinmura K, Yoshimura K, Shimizu K, Katai H, Beppu Y, Moriya H, Yokota J. Absence of germline CHK2 mutations in familial gastric cancer. Jpn J Cancer Res 2000;91:875-879.
  3. Yokoyama R, Beppu Y, Tobisu K, Moriya Y, Uchiyama K, Kito M, Umeda T, Hasegawa T, Shimoda T. A multidisciplinary approach to the treatment of malignant pelvic bone tumors: results with eight consecutive patients. J Orthop Sci 2000;5:449-456.
  4. Yokoyama R. Primary clear cell sarcoma of bone. Skeletal Radiol 2000;29:302.

Thoracic Surgery Division

  1. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Management of the bronchial stump in pulmonary resections: a review of 533 consecutive recent bronchial closures. Eur J Thorac-cardiovasc Surg 2000;17:106-110.
  2. Asamura H, Suzuki K, Kondo H, Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer?: A prognostic significance of N1 lymph node metastasis. Ann Thorac Surg 2000;70:1839-1846.
  3. Okumura T, Asamura H, Kondo H, Matsuno Y, Tsuchiya R. Hemangioma of the rib. Jpn J Clin Oncol 2000;30:354-357.
  4. Yamaguchi T, Suzuki K, Asamura H, ,Kondo H, Niki T, Yamada T, Matsuno Y, Tsuchiya R. Lung carcinoma with polypoid growth in the main pulmonary artery: report of two cases. Jpn J Clin Oncol 2000;30:358-361.
  5. Okumura T, Asamura H, Suzuki K, Kondo H, Tsuchiya R. Intrapulmonary metastasis of non-small cell lung cancer: a prognostic assessment. J Thorac Cardiovasc Surg (in press)

Urology Division

  1. Arai Y, Egawa S, Tobisu K, Sagiyama K, Sumiyoshi Y, Hashine K, Kawakita M, Matsuda T, Matsumoto K, Fujimoto H, Okada T, Kakehi Y, Terachi T, Ogawa O. Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan. BJU Int 2000;85:287-294.
  2. Davis P, Hakama M, Hisamichi S, Kakizoe T, Sano T, Sugimura T. Report of thirteenth international symposium of the foumdation for promotion of cancer research: cancer screening - past, present and future. Jpn J Clin Oncol 2000;30:322-331.
  3. Kakehi Y, Kamoto T, Ogawa O, Kato T, Tobisu K, Akakura K, Egawa S, Usami M, Maeda O, Arai Y, Sumiyoshi Y, Kamiryo Y, Yoshid O. Clinical Significance of Nonpalpable prostate cancer with favorable biospy features in Japanese men. Eur Urol 2000;37:552-558.
  4. Kakizoe T. Asian studies of cancer chemoprevention: latest clinical results. Eur J Cancer 2000;36:1303-1309.
  5. Kakizoe T. Urologic oncology in the twenty-first century. World J Surg 2000;24:1167-1171.
  6. Kume H, Kanai Y, Tobisu K, Fujimoto H, Tomita K, Kakizoe T. Signet-ring cell carcinoma of the urinary bladder associated with transitional cell carcinoma of the right ureter. Scand J Urol Nephrol 2000;34:278-279.
  7.    Nagata C, Inaba S, Kawakami N, Kakizoe T, Shimizu H. Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 2000;36:14-18
  8. Wijkstrom H, Cohen SM, Garden RA, Kakizoe T, Schoenberg G., Steineck G., Tobisu K. Prevention and treatment of urothelial premalignant and malignant lesions. Scand J Urol Nephrol Suppl 2000;205:116-135.

Table of Contents